What replacement solution is used during plasmapheresis?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: October 2, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

Ask Question

Plasmapheresis Replacement Solutions

Plasmapheresis is performed using albumin (with or without crystalloid) or fresh frozen plasma (FFP) as replacement solutions, with the choice depending on the clinical indication. 1

Primary Replacement Solutions

The two main replacement fluids used during therapeutic plasma exchange are:

Albumin-Based Solutions (Most Common)

  • 4-5% human serum albumin in saline is the preferred replacement solution for most plasmapheresis procedures 2
  • Blood is reconstituted with exogenous albumin and/or crystalloid after plasma removal 1
  • Albumin solutions are:
    • Pasteurized for viral inactivation
    • Associated with lower rates of allergic reactions and fever compared to FFP
    • More convenient to store and administer (no thawing required)
    • Cost-effective 2

Fresh Frozen Plasma (FFP)

  • Used when replacement of all plasma constituents is necessary 2
  • Must be ABO-compatible with the patient 3
  • Pathogen-inactivated FFP is preferred when used for plasmapheresis, particularly in thrombocytopenic purpura 3
  • Typical volume: 1.0-1.5 times patient's plasma volume (40-60 mL/kg) 4

Clinical Decision Algorithm

Use FFP when:

  • Thrombotic thrombocytopenic purpura (TTP) - FFP is the standard replacement 4, 2
  • Pre-existing coagulopathy requiring factor replacement 2
  • Pregnancy-related TTP (FFP, cryo-poor plasma, or solvent detergent-treated plasma) 4

Use Albumin when:

  • Antibody-mediated rejection in transplantation 1
  • Most other indications where coagulation factor replacement is not required 2
  • Desensitization protocols
  • Autoimmune neurological conditions

Combination Protocols

Albumin + Hydroxyethyl Starch (HES) shows the best safety profile in comparative studies:

  • Lowest incidence of fever, allergic reactions, and hypocalcemia 5
  • Better hemodynamic tolerance than albumin alone 5
  • Best cost-effectiveness ratio 5

Important Caveats

Complication Profiles Differ by Solution:

  • FFP causes more: Urticaria (17%), pruritus (13%), fever, and allergic reactions 6
  • Albumin causes more: Hypotension (particularly with albumin-saline combinations) and hypocalcemic symptoms (8.2%) 6
  • Overall complication rate: 42% with FFP vs 30% with albumin-saline (p<0.0001) 6

Practical Considerations:

  • FFP requires blood type matching and advance ordering/thawing 2
  • Albumin causes transient mild deficiencies of plasma proteins, which is clinically acceptable in most cases 2
  • Neither cryosupernatant nor solvent-detergent pooled plasma has shown superior outcomes to standard FFP for any indication 2

Volume Considerations:

The typical exchange volume is 1.0-1.5 plasma volumes (approximately 40-60 mL/kg body weight) 7, 4

Bottom line: Choose albumin-based solutions for most indications due to superior safety profile and convenience; reserve FFP specifically for TTP and conditions requiring coagulation factor replacement.

References

Related Questions

What volume of 5% albumin should be used as replacement fluid during therapeutic plasma exchange for a 70‑kg adult lung‑transplant recipient?
A 10‑day postpartum woman presents with dysuria and a urine culture growing mixed microbiota >100,000 CFU/mL; how should this be managed?
What is the appropriate 10‑day antibiotic regimen for a patient undergoing ENT follow‑up after image‑guided fine‑needle aspiration/biopsy, assuming no documented β‑lactam allergy?
In a 10‑month‑old infant with a slightly indented coronal suture, normal fontanelles, and appropriate head growth, what is the appropriate next step in management?
What is the minimum recommended duration of antimicrobial therapy for a deep puncture wound?
What is the appropriate intravenous regular insulin infusion protocol for a 70‑kg patient with severe hypertriglyceridemia?
What is the appropriate diagnostic workup and subsequent management plan for hilar cholangiocarcinoma?
What is the role of apixaban in treating thrombosed varicose veins?
In a 59-year-old patient with a 15‑day viral syndrome now presenting with worsening cough, fever, generalized decline, diffuse bilateral wheezes with bronchospasm, leukocytosis of 18 × 10⁹/L without left shift, who is already receiving amoxicillin‑clavulanate, prednisolone, and budesonide/formoterol twice daily, what is the next appropriate management?
In lung transplantation, what replacement solution is used for intra‑operative plasmapheresis?
Are patients with leukemia, particularly acute lymphoblastic leukemia (ALL) or acute myeloid leukemia (AML) with high leukocyte counts or bulky disease, at increased risk of developing tumor lysis syndrome (TLS)?

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.